Detlev Riesner logo

Detlev Riesner

Description

Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in Düsseldorf, Germany since 1980 and is Director of Technol...

Investor Profile

Detlev Riesner has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Manufacturing.

Stage Focus

  • Seed (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Manufacturing
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Detlev Riesner frequently co-invest with?

European Investment Fund
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
Evonik Venture Capital
Europe, Hessen, Germany, Hanau
Co-Investments: 1

Which angels does Detlev Riesner often collaborate with?

Shared Deals: 1

What are some of recent deals done by Detlev Riesner?

Pantherna Therapeutics

Hennigsdorf, Brandenburg, Germany

Pantherna Therapeutics is a privately-held biopharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics
SeedJul 3, 2019
Amount Raised: $3,950,976
Numaferm

Düsseldorf, Nordrhein-Westfalen, Germany

Numaferm is a Dusseldorf University spin-off that specializes in the biotechnical production.

BiotechnologyManufacturingPharmaceutical
SeedMay 13, 2017